LINC01094 and breast carcinoma: LINC01094 has been shown by many studies to promote the progression of various cancers by interacting with various miRNAs, including ovarian cancer 41, breast cancer 42, pancreatic cancer 43, renal clear cell tumor 44, glioma, etc. 45.